Abstract
The molecular diversity of marine secondary metabolites has been recognized for a number of years, and classic marine-derived excitatory amino acids (EAAs) such as kainic and domoic acid have been indispensable tools in neurobiological research. The recent discovery of the sponge-derived EAA dysiherbaine (DH, 1), a novel di-amino di-acid glutamate analogue with potent convulsant activity, underscores the relatively untapped potential of marine organisms to serve as sources of EAAs with unique structures and activities [1]. DH (1) has a number of pharmacological actions but binds with highest affinity to kainate receptors, a sub-family of non-N-methyl-D-aspartate (non-NMDA)-type GluRs, which are also the molecular targets of other potent EAA convulsants like domoic acid. The high affinity and selectivity of 1 towards certain kainate receptor subtypes made it a useful tool for exploring aspects of the biophysical function of these ion channels [2]. In combination with chemical syntheses and neurophysiological techniques, we have shown that 1 and its structural analogues can serve as unique biophysical and physiological probes of GluR function [3]. Current studies have begun to elucidate the critical moieties on 1 that confer activity and selectivity. We anticipate that 1 will serve as a useful template upon which to build molecules with novel pharmacological actions and potential therapeutic applications. In this review, we describe the chemical, pharmacological and behavioral profile of 1 and closely related analogues, with a particular emphasis on their actions on iGluRs, a family of ligand-gated ion channel critical for excitatory neurotransmission in the mammalian brain.
Keywords: Dysiherbaines, excitatory amino acid, glutamate receptors, marine natural products, kainate receptors, convulsant, synthesis
Central Nervous System Agents in Medicinal Chemistry
Title: Dysiherbaine: A New Generation of Excitatory Amino Acids of Marine Origin
Volume: 6 Issue: 2
Author(s): Ryuichi Sakai, Geoffrey T. Swanson, Makoto Sasaki, Keiko Shimamoto and Hisao Kamiya
Affiliation:
Keywords: Dysiherbaines, excitatory amino acid, glutamate receptors, marine natural products, kainate receptors, convulsant, synthesis
Abstract: The molecular diversity of marine secondary metabolites has been recognized for a number of years, and classic marine-derived excitatory amino acids (EAAs) such as kainic and domoic acid have been indispensable tools in neurobiological research. The recent discovery of the sponge-derived EAA dysiherbaine (DH, 1), a novel di-amino di-acid glutamate analogue with potent convulsant activity, underscores the relatively untapped potential of marine organisms to serve as sources of EAAs with unique structures and activities [1]. DH (1) has a number of pharmacological actions but binds with highest affinity to kainate receptors, a sub-family of non-N-methyl-D-aspartate (non-NMDA)-type GluRs, which are also the molecular targets of other potent EAA convulsants like domoic acid. The high affinity and selectivity of 1 towards certain kainate receptor subtypes made it a useful tool for exploring aspects of the biophysical function of these ion channels [2]. In combination with chemical syntheses and neurophysiological techniques, we have shown that 1 and its structural analogues can serve as unique biophysical and physiological probes of GluR function [3]. Current studies have begun to elucidate the critical moieties on 1 that confer activity and selectivity. We anticipate that 1 will serve as a useful template upon which to build molecules with novel pharmacological actions and potential therapeutic applications. In this review, we describe the chemical, pharmacological and behavioral profile of 1 and closely related analogues, with a particular emphasis on their actions on iGluRs, a family of ligand-gated ion channel critical for excitatory neurotransmission in the mammalian brain.
Export Options
About this article
Cite this article as:
Sakai Ryuichi, Swanson T. Geoffrey, Sasaki Makoto, Shimamoto Keiko and Kamiya Hisao, Dysiherbaine: A New Generation of Excitatory Amino Acids of Marine Origin, Central Nervous System Agents in Medicinal Chemistry 2006; 6 (2) . https://dx.doi.org/10.2174/187152406777441907
DOI https://dx.doi.org/10.2174/187152406777441907 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis
Current Pharmaceutical Design High-Throughput Screening of Neuronal Cl- Channels: Why and How?
Current Neuropharmacology Somatic Genome Variations in Health and Disease
Current Genomics Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management
Current Pharmaceutical Design Role of Positron Emission Tomography for Central Nervous System Involvement in Systemic Autoimmune Diseases: Status and Perspectives
Current Medicinal Chemistry Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Endocannabinoid System May Modulate Sleep Disorders in Aging
Current Neuropharmacology Meet the Editorial Board
CNS & Neurological Disorders - Drug Targets Lamotrigine Pharmacokinetics During Anticonception and Pregnancy
Letters in Drug Design & Discovery The Role of Adenosine in Alzheimers Disease
Current Neuropharmacology Brain Hyperthermia During Physiological and Pathological Conditions: Causes, Mechanisms, and Functional Implications
Current Neurovascular Research Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study
Central Nervous System Agents in Medicinal Chemistry 1,2,4-Triazine Analogs as Novel Class of Therapeutic Agents
Mini-Reviews in Medicinal Chemistry Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer’s Disease
Current Protein & Peptide Science Extracellular Vesicles in Glioblastoma: Role in Biological Processes and in Therapeutic Applications
Current Cancer Drug Targets Erythropoietin and mTOR: A “One-Two Punch” for Aging-Related Disorders Accompanied by Enhanced Life Expectancy
Current Neurovascular Research Role of Kynurenines in the Central and Peripherial Nervous Systems
Current Neurovascular Research The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases
Current Pharmaceutical Design Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued) Recent Updates on Biological Activities of Oxadiazoles
Mini-Reviews in Medicinal Chemistry